Eli Lilly has outstanding growth prospects thanks to its leadership in its core therapeutic area. AbbVie’s immunosuppressant portfolio helps it to produce steady revenue and profits.
Source: https://www.fool.com/investing/2026/01/19/best-healthcare-st…
Every market cycle creates a new group of instant experts who promise you the next hot trade, the next AI moonshot, or the one stock that will make you rich by Friday afternoon.
An excellent earnings report from Palantir Technologies wasn’t enough to lift the software company’s own stock. It wasn’t helping other software stocks on Tuesday, either.
Robust online betting demand bodes well for the Gaming industry. Stocks like LVS, RSI and BRSL benefit from improving industry trends.
